- Home
- GGN vs IRMD Comparison
GGN vs IRMD Comparison
Compare GGN & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGN
- IRMD
- Stock Information
- Founded
- GGN 2005
- IRMD 1992
- Country
- GGN United States
- IRMD United States
- Employees
- GGN N/A
- IRMD N/A
- Industry
- GGN Finance/Investors Services
- IRMD Medical/Dental Instruments
- Sector
- GGN Finance
- IRMD Health Care
- Exchange
- GGN Nasdaq
- IRMD Nasdaq
- Market Cap
- GGN 640.3M
- IRMD 552.9M
- IPO Year
- GGN N/A
- IRMD 2014
- Fundamental
- Price
- GGN $4.22
- IRMD $49.74
- Analyst Decision
- GGN
- IRMD Strong Buy
- Analyst Count
- GGN 0
- IRMD 1
- Target Price
- GGN N/A
- IRMD $60.00
- AVG Volume (30 Days)
- GGN 397.4K
- IRMD 47.5K
- Earning Date
- GGN 01-01-0001
- IRMD 11-01-2024
- Dividend Yield
- GGN 10.26%
- IRMD 1.24%
- EPS Growth
- GGN N/A
- IRMD 25.06
- EPS
- GGN N/A
- IRMD 1.46
- Revenue
- GGN N/A
- IRMD $69,483,811.00
- Revenue This Year
- GGN N/A
- IRMD $12.98
- Revenue Next Year
- GGN N/A
- IRMD $10.77
- P/E Ratio
- GGN N/A
- IRMD $33.20
- Revenue Growth
- GGN N/A
- IRMD 16.05
- 52 Week Low
- GGN $3.51
- IRMD $36.12
- 52 Week High
- GGN $3.91
- IRMD $50.93
- Technical
- Relative Strength Index (RSI)
- GGN 59.67
- IRMD 62.93
- Support Level
- GGN $4.04
- IRMD $44.58
- Resistance Level
- GGN $4.24
- IRMD $48.23
- Average True Range (ATR)
- GGN 0.06
- IRMD 1.37
- MACD
- GGN 0.01
- IRMD 0.20
- Stochastic Oscillator
- GGN 85.00
- IRMD 78.90
About GGN GAMCO Global Gold Natural Resources & Income Trust
GAMCO Global Gold Natural Resources & Income Trust is a non-diversified closed-end management investment company. Its primary investment objective is to provide a high current income and capital appreciation as its secondary objective. To achieve its objective, the fund may invest majority of its assets in equity securities of companies principally engaged in the gold and natural resources industries. It also intends to earn income through an option strategy of writing (selling) covered call options on equity securities in its portfolio.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.